The Consumer Operated and Oriented Plan (CO-OP) Advisory Board; Office of Consumer Information and Insurance Oversight, January 13, 2011, 81612-81613 [2010-32649]

Download as PDF 81612 Federal Register / Vol. 75, No. 248 / Tuesday, December 28, 2010 / Notices information, including the validity of the methodology and assumptions used; (3) Enhance the quality, utility, and clarity of the information to be collected; and (4) Minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. Direct Comments to OMB: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the: Office of Management and Budget, Office of Regulatory Affairs, OIRA_submission@omb.eop.gov or by fax to 202–395–6974, Attention: Desk Officer for NIH. To request more information on the proposed project or to obtain a copy of the data collection plans and instruments, contact Patricia Newman, Program Analyst, Office of Science Policy, National Center for Research Resources, 6701 Democracy Boulevard, MSC 4874, Bethesda, Maryland 20892–4874, or e-mail your request, including your address to pnewman@mail.nih.gov. Comments Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication. Dated: December 20, 2010. Meryl Sufian, Supervisory Health Science Policy Analyst, Office of Science Policy, NCRR, National Institutes of Health. [FR Doc. 2010–32659 Filed 12–27–10; 8:45 am] BILLING CODE 4140–01–P FOR FURTHER INFORMATION CONTACT: Karen Gorirossi or Sheila Fleming at 240–453–8800. SUPPLEMENTARY INFORMATION: I. Background In FR Doc. 2010–29867 of November 29, 2010 (75 FR 73084–73085), there was an error, which included an incorrect date of implementation of administrative actions. The error is identified and corrected in the Correction of Errors section below. II. Correction of Errors In FR Doc. 2010–29867 of November 29, 2010 (75 FR 73084–73085), make the following corrections: 1. On page 73084, third column, fourth paragraph, change the paragraph to read as follows: ‘‘By letter dated October 4, 2010, the Department of Health and Human Services (HHS) notified Dr. Sezen of findings of misconduct in science made by ORI and the Department’s intent to debar her for a period of five (5) years pursuant to the Public Health Service Policies on Research Misconduct, 42 CFR part 50, subpart A and part 93, and HHS’ Implementation (2 CFR part 376) of the Office of Management and Budget (OMB) Guidelines to Agencies on Governmentwide Debarment and Suspension (2 CFR part 180). In accordance with part 93, subpart E, Dr. Sezen was afforded 30 days within which to request a hearing in this matter. As of November 4, 2010, the period of time to request a hearing expired. Thus, the following administrative actions have been implemented for a period of five (5) years, beginning on December 13, 2010.’’ Dated: December 17, 2010. John Dahlberg, Director, Division of Research Investigations, Office of Research Integrity. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2010–32555 Filed 12–27–10; 8:45 am] Office of the Secretary BILLING CODE 4150–31–P Findings of Misconduct in Science; Correction DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary, HHS ACTION: Correction of notice. AGENCY: [Docket No. HHS–OS–2010–0033; OCIIO– 9984–N] This document corrects errors that appeared in the notice published in the November 29, Federal Register entitled ‘‘Findings of Misconduct in Science.’’ emcdonald on DSK2BSOYB1PROD with NOTICES SUMMARY: Effective Date: December 28, 2010. Applicability Date: The correction notice is applicable for the Findings of Misconduct in Science notice published on November 29, 2010. DATES: VerDate Mar<15>2010 23:49 Dec 27, 2010 Jkt 223001 The Consumer Operated and Oriented Plan (CO–OP) Advisory Board; Office of Consumer Information and Insurance Oversight, January 13, 2011 Office of Consumer Information and Insurance Oversight (OCIIO), HHS. ACTION: Notice of meeting. AGENCY: This notice announces a forthcoming meeting of an advisory SUMMARY: PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 committee of the Office of Consumer Information and Insurance Oversight (OCIIO) in accordance with the Federal Advisory Committee Act. The meeting is open to the public. The purpose of the meeting is to assist and advise the Secretary and Congress through the Department of Health and Human Services’ Office of Consumer Information and Insurance Oversight (OCIIO) on the Department’s strategy to foster the creation of qualified nonprofit health insurance issuers. Specifically, the Committee shall advise the Secretary and Congress concerning the award of grants and loans related to Section 1322 of the Affordable Care Act. In these matters, the Committee shall consult with all components of the Department, other federal entities, and non-federal organizations, as appropriate; and examine relevant data sources to assess the grant and loan award strategy to provide recommendations to OCIIO. Notice of this meeting is given under the Federal Advisory Committee Act (Pub. L. No. 92–463, 5 U.S.C., App. 2). DATES: Meeting Date: January 13, 2011 from 8 a.m. to 5 p.m., eastern standard time (e.s.t.). Deadline for Meeting Registration, Presentations and Comments: January 6, 2011, 5 p.m., e.s.t. Deadline for Requesting Special Accommodations: January 6, 2011, 5 p.m., e.s.t. ADDRESSES: Meeting Location: Jurys Hotel, 1500 New Hampshire Ave., NW., Washington, DC 20036. Meeting Online Access: To participate in this meeting via the Internet, go to https://www.readyshow.com/ and enter participant code 78030350. Meeting Phone Access: To participate in this meeting via phone, please dial into the toll free phone number 1–877– 366–0711, and enter the phone number password 78030350#. Meeting Registration, Presentations, and Written Comments: Brian Chiglinsky, Office of Consumer Information and Insurance Oversight, HHS, 200 Independence Avenue, SW., Washington, DC 20201, 202–260–6090, Fax: 202–260–6108, or contact by e-mail at brian.chiglinsky@hhs.gov. Registration: The meeting is open to the public, but attendance is limited to the space available. Persons wishing to attend this meeting must register by contacting the Analyst at the address listed in the ADDRESSES section of this notice or by telephone at number listed in the FOR FURTHER INFORMATION CONTACT section of this notice, by the date listed in the DATES section of this notice. E:\FR\FM\28DEN1.SGM 28DEN1 Federal Register / Vol. 75, No. 248 / Tuesday, December 28, 2010 / Notices FOR FURTHER INFORMATION CONTACT: Brian Chiglinsky, 202–260–6090. Press inquiries are handled through OCIIO’s Press Office at (202) 690–6343. SUPPLEMENTARY INFORMATION: emcdonald on DSK2BSOYB1PROD with NOTICES I. Background The purpose of the meeting is to assist and advise the Secretary and Congress through the Department of Health and Human Services’ Office of Consumer Information and Insurance Oversight (OCIIO) on the Department’s strategy to foster the creation of qualified nonprofit health insurance issuers. Specifically, the Committee shall advise the Secretary and Congress concerning the award of grants and loans related to Section 1322 of the Affordable Care Act. In these matters, the Committee shall consult with all components of the Department, other federal entities, and non-federal organizations, as appropriate; and examine relevant data sources to assess the grant and loan award strategy to provide recommendations to OCIIO. II. Meeting Agenda The committee will hear testimony from a number of individuals with experience and expertise in the market for health insurance and nonprofit cooperative health issuers. OCIIO intends to make background material available to the public no later than two (2) business days prior to the meeting. If OCIIO is unable to post the background material on its Web site prior to the meeting, it will be made publicly available at the location of the advisory committee meeting, and the background material will be posted on OCIIO’s Web site after the meeting, at https://hhs.gov/ociio. Oral comments from the public will be scheduled between approximately 3 p.m. to 4 p.m. Individuals or organizations that wish to make a 3-minute oral presentation on an agenda topic should submit a written copy of the oral presentation to the DFO at the address listed in the ADDRESSES section of this notice by the date listed in the DATES section of this notice. The number of oral presentations may be limited by the time available. Persons attending OCIIO’s advisory committee meetings are advised that the agency is not responsible for providing access to electrical outlets. If the number of speakers requesting to comment is greater than can be reasonably accommodated during the scheduled open public comment session, OCIIO will take written comments after the meeting until close of business. Individuals not wishing to make a presentation may submit written VerDate Mar<15>2010 22:37 Dec 27, 2010 Jkt 223001 comments to the DFO at the address listed in the ADDRESSES section of this notice by the date listed in the DATES section of this notice. Individuals requiring sign language interpretation or other special accommodations must contact the DFO via the contact information specified in the FOR FURTHER INFORMATION CONTACT section of this notice by the date listed in the DATES section of this notice. OCIIO is committed to the orderly conduct of its advisory committee meetings. Please visit our Web site at https://www.hhs.gov/ociio for procedures on public conduct during advisory committee meetings. Dated: December 21, 2010. Barbara Smith, Associate Director, Consumer Operated and Oriented Plan Program, Office of Consumer Information and Insurance Oversight. [FR Doc. 2010–32649 Filed 12–27–10; 8:45 am] BILLING CODE 4150–45–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–11–11BI] Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404–639–5960 and send comments to Carol Walker, Acting CDC Reports Clearance Officer, 1600 Clifton Road, MS–D74, Atlanta, GA 30333 or send an e-mail to omb@cdc.gov. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 81613 technology. Written comments should be received within 60 days of this notice. Proposed Project FoodNet Non-O157 Shiga ToxinProducing E. coli Study: Assessment of Risk Factors for Laboratory-Confirmed Infections and Characterization of Illnesses by Microbiological Characteristics—New—National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC). Background and Brief Description Each year many Shiga toxinproducing E. coli (STEC) infections occur in the United States, ranging in severity from mild diarrhea, to hemorrhagic colitis and in some cases, life-threatening hemolytic uremic syndrome (HUS). HUS occurs most frequently following infection with serogroup O157; 6% of patients with this type of STEC infection develop HUS, with highest occurrence in children aged <5 years. HUS has a fatality rate of approximately 5%; up to 25% of HUS survivors are left with chronic kidney damage. STEC are broadly categorized into two groups by their O antigens, STEC O157 and non-O157 STEC. The serogroup O157 is most frequently isolated and most strongly associated with HUS. Risk factors for STEC O157 infections in the United States and internationally have been intensely studied. Non-O157 STEC are a diverse group that includes all Shiga toxin-producing E. coli of serogroups other than O157. Over 50 STEC serogroups are known to have caused human illness. Numerous nonO157 outbreaks have been reported from throughout the world and clinical outcomes in some patients can be as severe as those seen with STEC O157 infections, however, little is known about the specific risk factors for infections due to non-O157 STEC serogroups. More comprehensive understanding of risk factors for sporadic non-O157 STEC infections is needed to inform prevention and control efforts. The FoodNet casecontrol study will be the first multistate investigation of non-outbreak-associated non-O157 STEC infections in the United States. It will investigate risk factors for non-O157 STEC infections, both as a group and individually for the most common non-O157 STEC serogroups. In addition, the study will characterize the major known virulence factors of nonO157 STEC to assess how risk factors and clinical features vary by virulence factor profiles. As the largest, most comprehensive, and most powerful E:\FR\FM\28DEN1.SGM 28DEN1

Agencies

[Federal Register Volume 75, Number 248 (Tuesday, December 28, 2010)]
[Notices]
[Pages 81612-81613]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-32649]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Docket No. HHS-OS-2010-0033; OCIIO-9984-N]


The Consumer Operated and Oriented Plan (CO-OP) Advisory Board; 
Office of Consumer Information and Insurance Oversight, January 13, 
2011

AGENCY: Office of Consumer Information and Insurance Oversight (OCIIO), 
HHS.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces a forthcoming meeting of an advisory 
committee of the Office of Consumer Information and Insurance Oversight 
(OCIIO) in accordance with the Federal Advisory Committee Act. The 
meeting is open to the public. The purpose of the meeting is to assist 
and advise the Secretary and Congress through the Department of Health 
and Human Services' Office of Consumer Information and Insurance 
Oversight (OCIIO) on the Department's strategy to foster the creation 
of qualified nonprofit health insurance issuers. Specifically, the 
Committee shall advise the Secretary and Congress concerning the award 
of grants and loans related to Section 1322 of the Affordable Care Act. 
In these matters, the Committee shall consult with all components of 
the Department, other federal entities, and non-federal organizations, 
as appropriate; and examine relevant data sources to assess the grant 
and loan award strategy to provide recommendations to OCIIO. Notice of 
this meeting is given under the Federal Advisory Committee Act (Pub. L. 
No. 92-463, 5 U.S.C., App. 2).

DATES: Meeting Date: January 13, 2011 from 8 a.m. to 5 p.m., eastern 
standard time (e.s.t.).
    Deadline for Meeting Registration, Presentations and Comments: 
January 6, 2011, 5 p.m., e.s.t.
    Deadline for Requesting Special Accommodations: January 6, 2011, 5 
p.m., e.s.t.

ADDRESSES: Meeting Location: Jurys Hotel, 1500 New Hampshire Ave., NW., 
Washington, DC 20036.
    Meeting Online Access: To participate in this meeting via the 
Internet, go to https://www.readyshow.com/ and enter participant code 
78030350.
    Meeting Phone Access: To participate in this meeting via phone, 
please dial into the toll free phone number 1-877-366-0711, and enter 
the phone number password 78030350.
    Meeting Registration, Presentations, and Written Comments: Brian 
Chiglinsky, Office of Consumer Information and Insurance Oversight, 
HHS, 200 Independence Avenue, SW., Washington, DC 20201, 202-260-6090, 
Fax: 202-260-6108, or contact by e-mail at brian.chiglinsky@hhs.gov.
    Registration: The meeting is open to the public, but attendance is 
limited to the space available. Persons wishing to attend this meeting 
must register by contacting the Analyst at the address listed in the 
ADDRESSES section of this notice or by telephone at number listed in 
the FOR FURTHER INFORMATION CONTACT section of this notice, by the date 
listed in the DATES section of this notice.

[[Page 81613]]


FOR FURTHER INFORMATION CONTACT: Brian Chiglinsky, 202-260-6090. Press 
inquiries are handled through OCIIO's Press Office at (202) 690-6343.

SUPPLEMENTARY INFORMATION:

I. Background

    The purpose of the meeting is to assist and advise the Secretary 
and Congress through the Department of Health and Human Services' 
Office of Consumer Information and Insurance Oversight (OCIIO) on the 
Department's strategy to foster the creation of qualified nonprofit 
health insurance issuers. Specifically, the Committee shall advise the 
Secretary and Congress concerning the award of grants and loans related 
to Section 1322 of the Affordable Care Act. In these matters, the 
Committee shall consult with all components of the Department, other 
federal entities, and non-federal organizations, as appropriate; and 
examine relevant data sources to assess the grant and loan award 
strategy to provide recommendations to OCIIO.

II. Meeting Agenda

    The committee will hear testimony from a number of individuals with 
experience and expertise in the market for health insurance and 
nonprofit cooperative health issuers. OCIIO intends to make background 
material available to the public no later than two (2) business days 
prior to the meeting. If OCIIO is unable to post the background 
material on its Web site prior to the meeting, it will be made publicly 
available at the location of the advisory committee meeting, and the 
background material will be posted on OCIIO's Web site after the 
meeting, at https://hhs.gov/ociio.
    Oral comments from the public will be scheduled between 
approximately 3 p.m. to 4 p.m. Individuals or organizations that wish 
to make a 3-minute oral presentation on an agenda topic should submit a 
written copy of the oral presentation to the DFO at the address listed 
in the ADDRESSES section of this notice by the date listed in the DATES 
section of this notice. The number of oral presentations may be limited 
by the time available. Persons attending OCIIO's advisory committee 
meetings are advised that the agency is not responsible for providing 
access to electrical outlets. If the number of speakers requesting to 
comment is greater than can be reasonably accommodated during the 
scheduled open public comment session, OCIIO will take written comments 
after the meeting until close of business. Individuals not wishing to 
make a presentation may submit written comments to the DFO at the 
address listed in the ADDRESSES section of this notice by the date 
listed in the DATES section of this notice.
    Individuals requiring sign language interpretation or other special 
accommodations must contact the DFO via the contact information 
specified in the FOR FURTHER INFORMATION CONTACT section of this notice 
by the date listed in the DATES section of this notice.
    OCIIO is committed to the orderly conduct of its advisory committee 
meetings. Please visit our Web site at https://www.hhs.gov/ociio for 
procedures on public conduct during advisory committee meetings.

    Dated: December 21, 2010.
Barbara Smith,
Associate Director, Consumer Operated and Oriented Plan Program, Office 
of Consumer Information and Insurance Oversight.
[FR Doc. 2010-32649 Filed 12-27-10; 8:45 am]
BILLING CODE 4150-45-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.